Logic Bio Therapeutics
Biotechnology, 65 Hayden Ave, Lexington, , 2421, Massachusetts, United States, 51-200 Employees
Phone Number: 16*********
Who is LOGICBIO THERAPEUTICS
We are a genome editing company developing genetic medicines for the fight against rare pediatric diseases. GeneRideTM is a promoterless and nuclease-free approach to gene insertion which...
Read More
-
Headquarters: 65 Hayden Ave, Lexington, Massachusetts, 2421, United States
-
Date Founded: 2014
-
Employees: 51-200
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from LOGICBIO THERAPEUTICS
LogicBio Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding LogicBio Therapeutics
Answer: LogicBio Therapeutics's headquarters are located at 65 Hayden Ave, Lexington, , 2421, Massachusetts, United States
Answer: LogicBio Therapeutics's phone number is 16*********
Answer: LogicBio Therapeutics's official website is https://logicbio.com
Answer: LogicBio Therapeutics's revenue is $25 Million to $50 Million
Answer: LogicBio Therapeutics's SIC: 2834
Answer: LogicBio Therapeutics's NAICS: 325412
Answer: LogicBio Therapeutics has 51-200 employees
Answer: LogicBio Therapeutics is in Biotechnology
Answer: LogicBio Therapeutics contact info: Phone number: 16********* Website: https://logicbio.com
Answer: We are a genome editing company developing genetic medicines for the fight against rare pediatric diseases. GeneRideTM is a promoterless and nuclease-free approach to gene insertion which may improve the safety profile of AAV based gene therapies With GeneRideTM, the therapeutic gene is site-specifically integrated into the genome allowing durable gene expression in dividing cells and mature tissues. Furthermore, therapeutic gene expression is regulated by the targeted locus so production can be limited to specific cell types. LogicBio has been acquired by Alexion, AstraZeneca Rare Disease. For future updates on our genome editing program, follow Alexion Pharmaceuticals.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month